Travere Therapeutics, Inc. TVTX Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by Travere Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.
The official record: Travere Therapeutics, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Travere Therapeutics, Inc.'s net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Travere Therapeutics, Inc.'s net change in cash?
- Travere Therapeutics, Inc. (TVTX) reported net change in cash of -$14.67M in Q1 2026.
- How has Travere Therapeutics, Inc.'s net change in cash changed year-over-year?
- Travere Therapeutics, Inc.'s net change in cash decreased by 536.4% year-over-year, from $3.36M to -$14.67M.
- What is the long-term trend for Travere Therapeutics, Inc.'s net change in cash?
- Over 3 years (2021 to 2024), Travere Therapeutics, Inc.'s net change in cash has grown at a -83.6% compound annual growth rate (CAGR), from $80.98M to $359K.
- What does net change in cash mean?
- Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.